Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

02. Oktober 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3086


	Artikel 1 - 20 / 61705

	Geographic Variations in Demographic, Stage at Diagnosis and Socioeconomic Profiles of Pancreatic Cancer Patients in the United States: A National Cancer Database Analysis (2004-2020). Anticancer Res Yadav A, Mahesh VA, Manaise HK, Kathuria N, Demirors B, Brock LF, Jimenez PB, Puri R, Merly AA, Mahesh NA, Veenstra B, Gabriel E. PMID: 42823168 [PubMed - indexed for MEDLINE]
	Association of Pretreatment Absolute Neutrophil Count and Prognostic Nutritional Index With Completion of Neoadjuvant Gemcitabine Plus S-1 in Resectable Pancreatic Cancer. Anticancer Res Suto H, Sakai H, Fujita AN, Muramatsu M, Wakamatsu R, Wakamatsu A, Katsuragawa M, Tanaya M, Hiura K. PMID: 42823160 [PubMed - indexed for MEDLINE]
	Stereotactic MRI-guided adaptive radiation therapy (SMART) for locally advanced pancreatic cancer: A prospective single-center cohort study. Radiother Oncol Hartfelt PB, Bisgaard ALH, Ejlsmark MW, Bahij R, Schytte T, Mahmood F, Pfeiffer P, Bernchou U. PMID: 42822782 [PubMed - as supplied by publisher]
	High SMAD4 Expression is Associated with Improved Clinical Outcomes in Patients with Resectable Pancreatic Cancer: An Analysis of NRG Oncology/RTOG 9704. Int J Radiat Oncol Biol Phys Williams TM, Moughan J, Regine WF, Timmers CD, Robb R, Cui T, DiPetrillo TA, Leasure NC, Kim H, Doncals DE, Narayan S, Bush DA, Henke LE, Delouya G, Haddock MG, Winter K, Guha C, Ben-Josef E. PMID: 42822544 [PubMed - as supplied by publisher]
	Importance of faecal sample collection in prospective cohort studies to evaluate the effect of the gut microbiome on cancer development. Lancet Microbe Vogtmann E, Um CY, Zouiouich S, Absher D, Benamouzig R, Chan AT, Fu J, Garrett WS, Greiser KH, Havulinna AS, Huttenhower C, Hveem K, Kushi LH, Lahti L, Liou JM, Lituev A, Michaëlsson K, Milne RL, Næss M, Niiranen TJ, Olsen A, Patel AV, Rimm EB, Rowell S, Salomaa V, Sayols-Baixeras S, Segal E, Shrubsole MJ, Shu XO, Skarbinski J, Song M, Southey MC, Tjønneland A, Veiga P, Weersma RK, Wu MS, Zheng W, Zhernakova A, Shi J, Hong HG, Abnet CC, Sinha R. PMID: 42822491 [PubMed - as supplied by publisher]
	Hydrogel biomaterial platforms for local pancreatic cancer therapy: Drug delivery, tissue interaction, and translational challenges. J Biomater Appl Renjie L, Xinyang P, Tianzhu Z. PMID: 42821995 [PubMed - as supplied by publisher]
	Imaging-based diagnosis of pancreatic cancer: a systematic review and meta-analysis of direct comparative studies. Eur Radiol Rezu, Rancz A, van Nieuwkerk JI, Said N, Eperjesi O, Mihai VC, Veres DS, Paczkó M, Obeidat M, Bunduc , Tamba BI, Hegyi P, Teutsch B. PMID: 42821086 [PubMed - as supplied by publisher]
	AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review. Clin Gastroenterol Hepatol Das KK, Serper M, Vege SS. PMID: 42820904 [PubMed - as supplied by publisher]
	Minimally Invasive Versus Open Total and Distal Gastrectomy After Chemotherapy for Gastric Cancer: A Nationwide Observational Study. Ann Gastroenterol Surg Hoshino N, Hirakawa S, Hisamori S, Tachimori H, Fujii Y, Kumagai K, Ueno H, Shirabe K, Obama K. PMID: 42819733 [PubMed - as supplied by publisher]
	Case Report: Delayed diagnosis of pancreatic solid pseudopapillary neoplasm in a boy initially misdiagnosed as traumatic retroperitoneal hematoma. Front Pediatr Zhou Z, Pan R, Li J, Li Z, Xiao Z. PMID: 42819326 [PubMed]
	Implementation of risk prediction models using electronic health data for early detection of pancreatic cancer: a prospective pilot feasibility study. medRxiv Wu BU, Luong TQ, Lustigova E, Jeon C, Puttock EJ, Moon RH, Munis MA, Chen W. PMID: 42818416 [PubMed]
	Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial. Nat Med Garcia-Carbonero R, Pazo Cid R, Macarulla T, Laquente B, Nguyen A, Guillén-Ponce C, Muñoz A, Kim EJ, Cazorla M, Seery T, Lobo de Mena M, Nevala-Plagemann C, Sharma V, Martínez de Castro E, Hojouj M, Le C, Mato-Berciano A, Connelly S, Kaleko M, Rojas LA, Wacher VJ, Shallcross MA, Blasco C, Cascallo M, Hidalgo M. PMID: 42816596 [PubMed - as supplied by publisher]
	Controversies in NEN: An ENETS position statement on the role of liver transplantation (LT) in patients with advanced small-intestinal and pancreatic NETs. J Neuroendocrinol Stålberg P, McNamara MG, Grozinsky-Glasberg S, Pascher A, Kos-Kudla B, Denecke T, Begum N, Martin W, Alband S, Dromain C, Srirajaskanthan R, Baudin E. PMID: 42816382 [PubMed - indexed for MEDLINE]
	Schedule-dependent efficacy of gemcitabine and RAS(ON) inhibition in orthotopic pancreatic cancer: implications for clinical trial design. Cancer Lett Gribbin KP, Halamish H, Siordia IR, Finan JM, Pishvaian MJ, Lopez CD, Kardosh A, Goodyear S, Sears RC, Zimmers T, Grossberg A, Byrne KT, Brody JR. PMID: 42815683 [PubMed - as supplied by publisher]
	Trends in Cyst Size of Resected Intraductal Papillary Mucinous Neoplasms Over Time-Has the Evolution of the International Association of Pancreatology (IAP) Guidelines Impacted Surgical Thresholds. J Gastrointest Surg Wong P, Pollini T, Hernandez S, Todeschini L, Maker AV. PMID: 42815619 [PubMed - as supplied by publisher]
	Palliative Care for Advanced Cancer in Medicare Advantage and Physician Networks. JAMA Netw Open Hu X, Jiang C, Kwon Y, Fan Q, Shi KS, Zheng Z, Zhao J, Pollack CE, Blackford AL, Warren JL, Han X, Yabroff KR. PMID: 42814462 [PubMed - indexed for MEDLINE]
	(177)Lu-labeled amidoxime-functionalized biodegradable microspheres for transarterial radioembolization of hepatocellular carcinoma. Precis Radiat Oncol Liu X, Wang G, Zhao Z, Wang H, Chen H, Xu X, Li J, Ma H. PMID: 42812750 [PubMed - as supplied by publisher]
	Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives. Nat Commun Raufi AG, D'Souza EK, May MS, Sedycias S, Pellicciotta I, Pan S, Wang S, Palermo C, Sastra S, Sender N, Ross I, Li L, Luthria K, Shah P, Tagore S, Walsh ZH, Turk A, Sema B, Iuga A, Dajiang S, Kluger MD, Schrope BA, Brown D, Fojo T, Schvartzman JM, Pumpalova Y, Moy RH, Bates S, Wu L, Hibshoosh H, Tan AC, Schwartz GK, Chabot JA, Olive KP, Izar B, Manji GA. PMID: 42811017 [PubMed - indexed for MEDLINE]
	Interleukin-35 and pancreatic cancer: research progress from tumor-promoting mechanisms to treatment resistance. Cytokine Guo Y, Liang J, Liu X, Wang L, Li W, Song M, Wang X, Liu Y, Li Z, Li S, Fu N, Zhang B. PMID: 42810078 [PubMed - as supplied by publisher]
	Real-world implementation of a decision aid for treatment decisions in metastatic pancreatic cancer: a prospective multicenter study across expert centers. Oncologist Graus MUJE, Broekman THT, van Nassau S, Pepels-Aarts N, Cirkel GA, den Dulk M, Haberkorn BCM, van Hellemond IEG, Hermans KEPE, Homs MYV, Los M, Luelmo SAC, Mulder SF, Streppel MM, Wumkes ML, Wilmink JW, de Hingh IHJT, Valkenburg-van Iersel LBJ, de Vos-Geelen J, Dutch Pancreatic Cancer Group. PMID: 42809229 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 61705

Seite 1 von 3086



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung